Immunotherapy breakthrough: Pembrolizumab extends time to recurrence in aggressive bladder cancer Post author: Post published:January 27, 2024 Post category:uncategorized Patients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new treatment option. You Might Also Like Excessive social media use linked to increased smoking and vaping among youth May 20, 2024 Food-as-medicine could save billions in healthcare costs—here’s what’s standing in its way April 8, 2025 Analysis reveals overutilization of imaging in Bell’s palsy November 14, 2025
Food-as-medicine could save billions in healthcare costs—here’s what’s standing in its way April 8, 2025